Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
BROOKS LABORATORIES LTD.
Brooks Laboratories Ltd.
NSE: BROOKS | BSE: 533543
Slowing Down Stock
Download real time
86.31
-3.69
(
-4.10
%)
New 52W Low today
71,677
NSE+BSE Volume
High volume today
NSE
26 Dec, 2025 3:31 PM (IST)
Watchlist
Portfolio
Alert
My Notes
TRADE STOCK
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Brooks Laboratories - BROOKS, 533543 corporate action history
Check all corporate actions such as stock splits, bonuses, dividends, mergers & acquisitions, rights issues & board meeting announcements for Brooks Laboratories
GET EVENTS ALERTS
LIVE SAMPLE
Daily Digest
Brooks Laboratories Bonus history
Brooks Laboratories has not announced any bonus since Jan 1, 2000.
See all forthcoming Bonus and Splits
Brooks Laboratories Split history
Brooks Laboratories has not split the face value of the share since Jan 1, 2000.
See all forthcoming Bonus and Splits
Brooks Laboratories Dividend history
Brooks Laboratories has not given any dividends since Jan 1, 2000.
See all forthcoming dividends
Board Meetings - Brooks Laboratories
The latest board meeting for Brooks Laboratories took place on 14 Nov 2025, for the purpose of Quarterly Results
Ex-Date
Purpose
Notes
14 Nov 2025
Quarterly Results
-
13 Aug 2025
Quarterly Results
-
28 May 2025
Audited Results
-
13 Feb 2025
Quarterly Results
-
11 Dec 2024
To consider Fund Raising & Others
Inter-alia, to consider and approve 1. Proposal for Raising Funds through the issuance of securities (Equity Shares) by way of a preferential issue. 2. To approve the EGM. 3. Other business matters.
09 Nov 2024
Quarterly Results
-
14 Aug 2024
Quarterly Results
-
18 May 2024
Audited Results
-
31 Jan 2024
Quarterly Results
-
24 Jan 2024
Rights & Preferential issue
-
See all Board Meetings for Brooks Laboratories
Rights history for Brooks Laboratories
Brooks Laboratories issued rights 2 times since Feb. 11, 2020. Brooks Laboratories had last issued Rights shares of ₹10.0/- in the ratio of 1.0:16.0 @ premium of ₹65.0/- on July 28, 2023.
Ex-Date
Ratio
Face Value
Premium
Record Date
28 Jul 2023
1.0:16.0
10.0
65.0
28 Jul 2023
11 Feb 2020
9.0:20.0
10.0
10.0
12 Feb 2020
See all Rights History for Brooks Laboratories